CCRC - Certified Clinical Research Coordinator Participant Safety & AE Reporting Questions and Answers

Question 1

A study participant in a clinical trial for a new hypertension medication reports a persistent, severe headache. The headache is listed in the Investigator's Brochure as a possible side effect. According to ICH GCP guidelines, how should this event be classified?

Accepted Answer

As an Adverse Event (AE).

Answer

An Adverse Event (AE) is any untoward medical occurrence in a patient or clinical investigation subject administered a pharmaceutical product, which does not necessarily have a causal relationship with this treatment. Since the headache is a medical occurrence during the trial, it is an AE. It is not an SAE because it does not meet the criteria for seriousness (e.g., life-threatening, requiring hospitalization). Severity (severe headache) is not the same as seriousness. It is not a UPIRSO because the event was anticipated (listed in the Investigator's Brochure). It is not a protocol deviation, but rather a clinical event to be documented and reported per protocol.

Question 2

A Clinical Research Coordinator (CRC) is notified that a study participant has been hospitalized due to a suspected reaction to the investigational drug. According to FDA regulations for IND trials, what is the maximum timeframe for the sponsor to report this unexpected fatal or life-threatening suspected adverse reaction to the FDA?

Accepted Answer

As soon as possible, but no later than 7 calendar days.

Answer

FDA regulation 21 CFR 312.32(c)(2) requires sponsors to notify the FDA of any unexpected fatal or life-threatening suspected adverse reaction as soon as possible, but in no case later than 7 calendar days after the sponsor's initial receipt of the information. The 15-day timeframe applies to other serious and unexpected suspected adverse reactions.

Question 3

Which of the following is a primary responsibility of the Clinical Research Coordinator (CRC) in the management of adverse events?

Accepted Answer

Ensuring accurate and timely documentation of the event in the source documents and Case Report Forms (CRFs).

Answer

The CRC plays a critical role in ensuring that all adverse events are accurately and promptly documented in the participant's source records and transcribed correctly onto the CRFs. While the CRC assists in collecting information, the Principal Investigator is ultimately responsible for the causality assessment. The sponsor, not the site CRC, is responsible for reporting SAEs to the FDA. Protocol modifications are the responsibility of the sponsor.

Question 4

During a Phase III trial, a participant experiences an allergic reaction resulting in anaphylactic shock, which requires emergency intervention and hospitalization. This specific type of reaction was not previously identified in the Investigator's Brochure. This event should be categorized as a:

Accepted Answer

Suspected Unexpected Serious Adverse Reaction (SUSAR).

Answer

This event is a SUSAR because it meets all three criteria: It is Serious (life-threatening, requires hospitalization), Unexpected (not listed in the Investigator's Brochure), and a suspected Adverse Reaction (a causal relationship is suspected). While it is an SAE, the more specific and complete classification is SUSAR, which triggers expedited reporting to regulatory authorities by the sponsor.

Question 5

What key factor distinguishes a 'Serious Adverse Event' (SAE) from a non-serious adverse event according to ICH GCP guidelines?

Accepted Answer

The outcome or consequence of the event meeting specific criteria.

Answer

An SAE is defined by its outcome. According to ICH E6 and FDA definitions, an event is serious if it results in death, is life-threatening, requires or prolongs hospitalization, results in persistent or significant disability/incapacity, is a congenital anomaly/birth defect, or requires intervention to prevent permanent impairment. Severity is a separate scale and does not automatically make an AE serious. Relatedness and frequency are important for overall safety assessment but do not define 'seriousness'.

CCRC - Certified Clinical Research Coordinator Practice Test

CCRC - Certified Clinical Research Coordinator Practice Test

CCRC - Certified Clinical Research Coordinator Participant Safety & AE Reporting Questions and Answers